139 related articles for article (PubMed ID: 36401483)
1. A case report of small cell ovarian neuroendocrine carcinoma combined with immunochemotherapy.
Zhu YX; Gao XP; Xin L; Jia YC
Medicine (Baltimore); 2022 Nov; 101(46):e31445. PubMed ID: 36401483
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
Monk BJ; Colombo N; Oza AM; Fujiwara K; Birrer MJ; Randall L; Poddubskaya EV; Scambia G; Shparyk YV; Lim MC; Bhoola SM; Sohn J; Yonemori K; Stewart RA; Zhang X; Perkins Smith J; Linn C; Ledermann JA
Lancet Oncol; 2021 Sep; 22(9):1275-1289. PubMed ID: 34363762
[TBL] [Abstract][Full Text] [Related]
3. Complete remission of ovarian small cell carcinoma treated with irinotecan and cisplatin: a case report.
Saitoh-Sekiguchi M; Nakahara K; Kojimahara T; Ohta T; Kawagoe J; Ohnuki T; Hayasaka T; Motoyama T; Kurachi H
Anticancer Res; 2007; 27(4C):2685-7. PubMed ID: 17695433
[TBL] [Abstract][Full Text] [Related]
4. Primary pure large cell neuroendocrine carcinoma of the ovary: A rare case report and review of literature.
Peng X; Wang H
Medicine (Baltimore); 2020 Dec; 99(49):e22474. PubMed ID: 33285672
[TBL] [Abstract][Full Text] [Related]
5. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
[TBL] [Abstract][Full Text] [Related]
6. Pathological features, clinical presentations and prognostic factors of ovarian large cell neuroendocrine carcinoma: a case report and review of published literature.
Yang X; Chen J; Dong R
J Ovarian Res; 2019 Jul; 12(1):69. PubMed ID: 31345245
[TBL] [Abstract][Full Text] [Related]
7. Primary small cell neuroendocrine carcinoma of the tonsil: a case report and review of the literature.
Wang HY; Zou J; Zhou GY; Yan JQ; Liu SX
Int J Clin Exp Pathol; 2014; 7(5):2678-82. PubMed ID: 24966986
[TBL] [Abstract][Full Text] [Related]
8. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus.
Katada C; Komori S; Yoshida T; Kawakami S; Watanabe A; Ishido K; Azuma M; Wada T; Hosoda K; Yamashita K; Hiki N; Tanabe S; Ishiyama H; Koizumi W
Esophagus; 2020 Apr; 17(2):135-140. PubMed ID: 31321580
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
11. [Conversion Surgery after Etoposide/Cisplatin(EP)Therapy for Huge Pancreatic Neuroendocrine Carcinoma - A Case Report].
Nakazawa A; Mitsui T; Miyata Y; Ninomiya R; Komagome M; Maki A; Ozawa F; Beck Y
Gan To Kagaku Ryoho; 2018 Mar; 45(3):530-532. PubMed ID: 29650928
[TBL] [Abstract][Full Text] [Related]
12. Giant small-cell neuroendocrine carcinoma infiltrating the heart.
Płatek AE; Kowalik R; Szymanski FM; Filipiak KJ
Kardiol Pol; 2018; 76(6):1023. PubMed ID: 29905370
[No Abstract] [Full Text] [Related]
13. Primary ovarian undifferentiated non-small cell carcinoma, neuroendocrine type.
Behnam K; Kabus D; Behnam M
Gynecol Oncol; 2004 Jan; 92(1):372-5. PubMed ID: 14751189
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine small cell rectal cancer metastasizing to the liver: a unique treatment strategy, case report, and review of the literature.
Al-Jiffry BO; Al-Malki O
World J Surg Oncol; 2013 Jul; 11():153. PubMed ID: 23844568
[TBL] [Abstract][Full Text] [Related]
15. [Treatment strategy for neuroendocrine carcinoma of the lung].
Kawase A; Nagai K
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1619-22. PubMed ID: 19838019
[TBL] [Abstract][Full Text] [Related]
16. Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas--a single institution experience.
Görner M; Brasch F; Hirnle P; Gehl HB; Scholtz LU; Wegehenkel K; Sudhoff H
Eur J Cancer Care (Engl); 2013 Sep; 22(5):648-52. PubMed ID: 23701280
[TBL] [Abstract][Full Text] [Related]
17. [Small cell neuroendocrine carcinoma of the bladder: A case report and review of the literature].
Chekrine T; De Bari B; Cassier P; Kulisa M; Chapet O; Mornex F
Cancer Radiother; 2011 Jun; 15(3):250-3. PubMed ID: 21420344
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of chemotherapy with cisplatin and 5-fluorouracil for recurrent small cell neuroendocrine carcinoma of the rectum: report of a case.
Okuyama T; Korenaga D; Tamura S; Yao T; Maekawa S; Watanabe A; Ikeda T; Sugimachi K
Surg Today; 1999; 29(2):165-9. PubMed ID: 10030743
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
Yuan L; Jiang H; Lu Y; Guo SW; Liu X
Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
Lung Cancer; 2006 Jul; 53(1):59-65. PubMed ID: 16716447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
